Ad
related to: gsk
Search results
Elegen Raises $35M in Series B Financing Round
GenomeWeb News· 3 days agoSynthetic DNA maker Elegen said Tuesday that it has raised $35 million in a Series B financing. Triatomic Capital led the round, joined by GSK and John Ballantyne, cofounder ...
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
Zacks via Yahoo Finance· 2 days agoThe traditional ways to plan for your retirement may mean income can no longer cover expenses...
UK announces funding to boost global fight against antimicrobial resistance
Center for Infectious Disease Research and Policy· 20 hours agoFleming Initiative Also announced at the meeting was a £45 million ($57 million) pledge by British...
William to attend celebration of efforts to tackle antimicrobial resistance
PA Media: Science via Yahoo News· 1 day ago“We must do more to tackle this threat and do it together, because it is too big to tackle without...
Moderna Stock Seesaws After The FDA Throws It A Curveball
Investor's Business Daily· 7 days agoThe FDA was due to make a decision by May 12. Moderna emphasized the FDA has not said it found any...
European stocks retreat ahead of key inflation release; HSBC falls
Investing.com via Yahoo Finance· 10 hours agoEuropean stock markets retreated marginally Friday, ahead of the release of key inflation data amid uncertainty over future interest rate moves. The main European indices closed lower Thursday ...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters· 7 days ago, opens new tab respiratory syncytial virus (RSV) vaccine due to "administrative constraints" and...
Do We Have Enough Bird Flu Vaccines for a Potential Pandemic?
Scientific American· 22 hours agoThe infection of dozens of cattle herds in the U.S. with the avian influenza virus H5N1 has raised...
Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade
InvestorPlace· 1 day agoSeveral drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical...
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 7 days agoShares recently broke out of a cup-with-handle base, topping a buy point at 115.89, according to...
